Related Experiment Video
Updated: Feb 3, 2026

Lumbar Intrathecal Injection of Gene Therapy Vectors for Central Nervous System Targeting in Mice and Rats
Published on: May 16, 2025
Compassionate use of gene therapies in pediatrics: An ethical analysis
Carolyn P Neuhaus1, Rachel L Zacharias1
1The Hastings Center, 21 Malcolm Gordon Road, Garrison, NY 10524, United States.
Insights
Compassionate use of CRISPR gene therapies for children raises ethical concerns. This commentary discusses impacts on research, therapy hype, and parental rights, urging careful consideration before pursuing these treatments outside clinical trials.
Area of Science:
- Bioethics
- Gene Therapy
- Pediatric Medicine
Background:
- Compassionate use programs have provided gene therapies to pediatric patients.
- Federal Right to Try laws may increase demand for investigational gene therapies outside clinical trials.
- Clinicians, parents, and companies require guidance on using CRISPR gene therapies compassionately for children.
Purpose of the Study:
- To raise concerns regarding the compassionate use of CRISPR-mediated gene therapies in pediatric and perinatal populations.
- To outline key considerations for parents, clinicians, and drug developers when evaluating compassionate use of these novel therapies for children.
Main Methods:
- Commentary based on ethical considerations and existing precedents.
- Analysis of potential impacts on scientific research and patient welfare.
- Discussion of parental authority in medical decision-making for investigational treatments.
Main Results:
- Identifies three critical issues surrounding compassionate use of CRISPR gene therapies in pediatric patients: effects on scientific research, the balance of hype versus harm, and the boundaries of parental decision-making authority.
- Highlights the need for support systems for all stakeholders involved in these complex decisions.
Conclusions:
- The compassionate use of CRISPR gene therapies in pediatric patients necessitates careful ethical deliberation.
- A balanced approach is required to weigh potential benefits against risks, research integrity, and parental rights.
- Further discussion and guidelines are needed to support informed decision-making in this evolving area of medicine.
Abstract:
In this commentary, we raise concerns about the compassionate use of CRISPR-mediated gene therapies in pediatric and perinatal patients. There is already a precedent for obtaining gene therapies for pediatric patients through compassionate use programs, and the recent passage of a federal Right to Try law may contribute to an increase in the number of patients who seek access to investigational products outside of a clinical trial. Clinicians, nurses, drug companies, and parents need support as they grapple with whether compassionate use of CRISPR-mediated gene therapies is the right thing to pursue for a child. We raise three issues to consider in that decision: (1) the effects of compassionate use on scientific research; (2) hype and harms of gene therapies; and (3) the limits and scope of parental authority.
Related Concept Videos
Gene Therapy
Ethics in Research
Ethics and Bioethics
Ethical Issues
Ethical Concerns in Healthcare:
Ethical Dilemmas II
Ethical Standards I
The Code of Ethics provisions outline the nurse's duty to the patient, the healthcare team, the profession, and society. The Code's fundamental principles include advocacy,...

